Related Content
March 26, 2014 โ Inspire MD Inc. has enrolled the first patient into the CARENET (CARotid Embolic protection study using ...
November 13, 2013 โ InspireMD Inc., a developer of embolic protection stents, announced 12-month results from the MGuard ...
August 1, 2013 โ InspireMD Inc. said the first patient has been enrolled in the Master II IDE clinical trial to evaluate ...
May 24, 2013 โ InspireMD Inc. announced new six-month results from the MASTER (MGuard for Acute ST Elevation Reperfusion ...
November 1, 2012 โ InspireMD Inc. announced that its proprietary MGuard embolic protection stent (EPS) was shown to be ...
February 6, 2012 โ InspireMD Inc. announced positive clinical results for its MGuard stent from a controlled randomized ...
July 29, 2011 โ InspireMD Inc., developer of the MGuard mesh protective stent system, announced that the first patient ...
December 17, 2010 โ Meta analysis data delivered at the Innovations in Interventional Cardiology 2010 meeting ...
September 28, 2010 โ A new multinational trial will examine the effectiveness of embolic protection mesh stents in STEMI ...
May 21, 2009 - InspireMD Ltd. said today it completed enrollment for the MAGICAL Trial (MGuard in Acute Myocardial) ...
March 26, 2014
